[Clinical pharmacology of the neuromuscular junction in myasthenia gravis. (Preliminary communication)].
D000777:Anesthetics / Q000009:adverse effects; D000900:Anti-Bacterial Agents / Q000009:adverse effects; D000927:Anticonvulsants / Q000009:adverse effects; D006801:Humans; D009157:Myasthenia Gravis / Q000503:physiopathology*; D009469:Neuromuscular Junction / Q000187:drug effects* / Q000503:physiopathology; D011619:Psychotropic Drugs / Q000009:adverse effects
D000777:Anesthetics; D000900:Anti-Bacterial Agents; D000927:Anticonvulsants; D011619:Psychotropic Drugs
Klinicka farmakologija neuromuskularne spojnice kod miastenije gravis. (Preliminarno saopćenje).